Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 176

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Anesthetic Agents and the Immature Brain: Are These Toxic or Therapeutic?

Anand, Kanwaljeet J.S., Soriano, Sulpicio G. · 2004 · Anesthesiology

Abstract

ABOUT 1.5 million fetuses or newborns are exposed to anesthetic agents each year.1After their initial report in Science 2suggesting that anesthetic drugs such as nitrous oxide, ketamine or other N -methyl-d-aspartate receptor antagonists lead to enhanced apoptosis in immature neurons, Olney et al. have reported that newborn rats exposed to commonly used anesthetic agents (isoflurane, midazolam, and nitrous oxide) also develop neurodegenerative changes in multiple areas of the brain, associated with long-term deficits in learning and memory.3The same investigators have reported similar neurodegenerative changes in rat pups exposed to other anesthetic agents, anticonvulsant drugs, or ethanol2,4–7and voiced their “concern that agents used in pediatric and obstetrical medicine for purposes of sedation, anesthesia, and seizure management may cause apoptotic neuronal death in the developing human brain.”5This has led to public outcry over the long-term effects of anesthesia or sedation given to pregnant women or to newborn infants requiring surgical operations after birth.8–13Calls for avoiding these agents in newborns raises the specter of surgical procedures being performed with minimal or no anesthesia, as was routine practice 20 years ago.14Accumulating data on the development of the pain-responsive15–19and stress-responsive20–22systems in the developing brain, together with increases in stress responses, morbidity, and mortality in lightly anesthetized neonates,23–25have led to the routine use of anesthesia and postoperative analgesia even for critically ill newborns.26,27Are the findings of Olney et al. significant enough to withhold anesthesia from neonates undergoing surgical operations or other invasive procedures? This issue needs to be addressed urgently, especially as no clinician would like to withhold anesthetics during a surgical procedure nor would any wish to expose their neonatal patients to potentially neurotoxic drugs.Brain development in preterm and term neonates is characterized by naturally occurring neuronal death by apoptotic mechanisms.28–30The cellular expression of regulator protein Bcl-2 and effector enzyme caspase-3 appear to mediate the increased vulnerability to neuronal apoptosis in the immature brain,31,32which affects more than 50 percent of cortical neurons after 28 weeks of human gestation.28An increased vulnerability to apoptosis is not limited to neurons but extends to immature oligodendroglia and astrocytes as well, particularly following free radical injury.33,34Immature neurons are also susceptible to excitotoxic damage because of an increased magnitude of ligand-gated calcium currents mediated via excitatory N -methyl-d-aspartate receptors,35–37ultimately leading to neuronal excitotoxic damage.38,39Accentuated neurodegenerative mechanisms in the immature brain thus increase neuronal susceptibility to various metabolic events (hypoglycemia, hypoxia, infection, ischemia, seizures) or exposure to anesthetic agents.40Anesthetic and anticonvulsant drugs that block N -methyl-d-aspartate receptors (e.g. , ketamine) or activate γ-amino butyric acid-type A receptors (e.g. , midazolam) consistently increase neuronal apoptosis in the neonatal brain,2–7suggesting that the physiologic simulation of N -methyl-d-aspartate receptors is necessary for neuronal synaptogenesis, differentiation, and survival during development. Lack of N -methyl-d-aspartate receptor activation by glutamate decreases synaptogenesis and cell-to-cell interactions.41,42Anesthetic agents directly suppress neuronal activation and also reduce extracellular concentrations of excitatory neurotransmitters,43thereby reducing the developmental inputs to immature neurons.In evaluating the clinical relevance of these findings, we must consider the major differences in complexity and adaptability between human and rodent brains and also the developmental differences between neonatal rats and humans.44,45Additional methodological issues to be considered before extrapolating these results to neonatal anesthesia in humans include (a) a prolonged duration of exposure to anesthetic agents; (b) the nutritional and metabolic needs of neonates receiving general anesthesia; (c) the routine use of continuous respiratory, hemodynamic, and other forms of monitoring and support during anesthesia; (d) dose-related effects of certain anesthetic agents; and (e) divergent effects of anesthetic drugs given in the presence or absence of surgical pain or stress. Each of these issues is discussed below.Neurodegenerative changes in the developing brain occurred following prolonged exposure to anesthesia in neonatal rats,2,6confirming earlier findings from exposure to halothane or N -methyl-d-aspartate receptor blockade.46,47From a developmental perspective, this duration of exposure would be equivalent to producing general anesthesia for several weeks in the human neonate,44which occurs rarely, if ever, in the clinical setting. Repeated ketamin

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00000542-200408000-00033

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 176

Metadata

Authors
Anand, K. J. S., & Soriano, S. G.
Venue
Anesthesiology
Published
2004-08-01
Volume
101
Issue
2
Pages
527-530
ISSN
0003-3022 (ISSN-L)
OpenAlex
W2098989477
Cited by
176
References
7
FWCI
3.28
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anesthetic Agents and the Immature Brain: Are These Toxic or Therapeutic? https://app.cochat.ai/papers/10.1097/00000542-200408000-00033
The paper
Anand, K. J. S., & Soriano, S. G. (2004). Anesthetic Agents and the Immature Brain: Are These Toxic or Therapeutic? Anesthesiology. https://doi.org/10.1097/00000542-200408000-00033

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.